Compile Data Set for Download or QSAR
Report error Found 219 Enz. Inhib. hit(s) with all data for entry = 50041965
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419670(CHEMBL1944691)
Affinity DataEC50:  0.158nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419668(CHEMBL1947157)
Affinity DataIC50: 0.200nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Guinea pig)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419675(CHEMBL1945032)
Affinity DataEC50:  0.200nMAssay Description:Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as reduction in methacholine-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419676(CHEMBL1945034)
Affinity DataEC50:  0.200nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419678(CHEMBL1945036)
Affinity DataIC50: 0.200nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Guinea pig)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419687(CHEMBL1947151)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as reduction in methacholine-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Guinea pig)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419670(CHEMBL1944691)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as reduction in methacholine-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419669(CHEMBL1944690)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419673(CHEMBL1944695)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419675(CHEMBL1945032)
Affinity DataEC50:  0.251nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419674(CHEMBL1945031)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419700(CHEMBL1944689)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419672(CHEMBL1944694)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Guinea pig)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419689(CHEMBL1945033)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as reduction in methacholine-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419682(CHEMBL1945041)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419671(CHEMBL1944693)
Affinity DataEC50:  0.316nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419665(CHEMBL1945299)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419701(CHEMBL1944692)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419678(CHEMBL1945036)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419689(CHEMBL1945033)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Guinea pig)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419688(CHEMBL1947152)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as reduction in methacholine-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419668(CHEMBL1947157)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Guinea pig)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419680(CHEMBL1945039)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at beta2 adrenoceptor in guinea pig trachea assessed as reduction in methacholine-induced contractionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419670(CHEMBL1944691)
Affinity DataIC50: 0.501nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419679(CHEMBL1945037)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419702(CHEMBL1945038)
Affinity DataIC50: 0.501nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419674(CHEMBL1945031)
Affinity DataIC50: 0.631nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419710(CHEMBL1946768)
Affinity DataIC50: 0.631nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50128690(SB-07499 | 4-Hydroxy-7-{2-[2-(3-phenethyloxy-propa...)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419680(CHEMBL1945039)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419703(CHEMBL1945042)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419662(CHEMBL1945294)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419699(CHEMBL1947156)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419683(CHEMBL1945043)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419669(CHEMBL1944690)
Affinity DataIC50: 0.631nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419663(CHEMBL1945297)
Affinity DataEC50:  0.794nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419679(CHEMBL1945037)
Affinity DataIC50: 0.794nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM25771(salmeterol xinafoate | 4-(1-hydroxy-2-{[6-(4-pheny...)
Affinity DataEC50:  0.794nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419687(CHEMBL1947151)
Affinity DataIC50: 0.794nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419704(CHEMBL1945289)
Affinity DataEC50:  0.794nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419671(CHEMBL1944693)
Affinity DataIC50: 0.794nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419696(CHEMBL1947153)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419684(CHEMBL1945044)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM86453(NSC_3083544 | CAS_73573-87-2 | Formoterol)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419703(CHEMBL1945042)
Affinity DataIC50: 1nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419702(CHEMBL1945038)
Affinity DataEC50:  1nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419706(CHEMBL1945296)
Affinity DataEC50:  1.30nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419665(CHEMBL1945299)
Affinity DataIC50: 1.60nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419677(CHEMBL1945035)
Affinity DataEC50:  1.60nMAssay Description:Agonist activity at human beta2 adrenoceptor expressed in H292 cells assessed as increase in cAMP accumulation after 60 mins by spectrophotometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
TargetBeta-2 adrenergic receptor(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50419698(CHEMBL1947155)
Affinity DataIC50: 2nMAssay Description:Displacement of radiolabeled iodocyanopindolol from recombinant beta2 adrenoceptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/22/2013
Entry Details Article
PubMed
Displayed 1 to 50 (of 219 total ) | Next | Last >>
Jump to: